Investigation on the anti-inflammatory and antioxidant effects of sulforaphane to exercise

Investigation on the anti-inflammatory and antioxidant effects of sulforaphane to exercise - Exercise sulforaphane trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045243

Enrollment

Registered

2021-08-24

Start date

2021-08-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy individuals

Interventions

Subjects ingest sulforaphane twice a day (200 micromollar) for 2 months. Subjects ingest placebo twice a day for 2 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy individuals aged 18-30

Exclusion criteria

Exclusion criteria: Abnormal findings on resting 12-lead electrocardiogram and/or blood pressure, Cannot limit alchol drinking the day before the experiment, Smoking or taking antioxidant supplements, Taking anti-allergy agent or anti-inflammatory agent

Design outcomes

Primary

Measure	Time frame
exercise purformance, physical conditions	—

Secondary

Measure	Time frame
biochemical indices, oxidative stress, inflammatory response	—

Countries

Japan

Contacts

Public ContactKatsuhiko Suzuki

Waseda Unicersity Faculty of Sport Sciences

katsu.suzu@waseda.jp04-2947-6898

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026